Moderna (NASDAQ:MRNA – Free Report) had its price objective decreased by Evercore ISI from $60.00 to $50.00 in a research ...

Merck shares trade at a significant discount to peers. The company faces challenges, but there are reasons to be bullish.

Research analysts at Leerink Partnrs issued their Q4 2025 earnings estimates for Moderna in a research note issued to ...

Kashmir's leading scientist and gastroenterologist, Prof M Sultran Khuroo writes about the evolution of the Human ...

Human Metapneumovirus (HMPV) does not affect pets, but misconceptions about its transmission persist. The virus targets human respiratory systems only, and pets cannot catch or spread HMPV.

The missive, released on Monday, is widely read in the biotech community where he has helped found dozens of companies, including Moderna. Combining human efforts, nature, and AI in what Afeyan ...

“Human Metapneumovirus (HMPV) is a common respiratory virus that causes an upper respiratory infection (like a cold). It is a seasonal disease that usually occurs in the winter and early spring ...

Shares of Moderna Inc. fell sharply on Monday after the biotech firm projected a steep decline in 2025 revenues, falling below Wall Street expectations. The company, known for its COVID-19 vaccine ...

But scientists at Moderna are in the late stages of testing what could be the first such shot, using mRNA technology against the virus. Here’s what to know about norovirus and where things stand ...

Antibiotics are ineffective against viral infections like human metapneumovirus (HMPV). HMPV affects the respiratory system, and antibiotics, designed to target bacteria, won't help. Misusing ...

Five years after the first cases of COVID-19, reports of hMPV, an obscure respiratory virus in China may understandably raise ...